Found 18 hits for monomerid = 50427453 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Bromodomain-containing protein 4 Bromo 1 domain(BRD4 BD1)
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 241 | n/a | n/a | n/a | n/a | n/a | n/a |
SignalRx Pharmaceuticals, Inc.
US Patent
| Assay Description Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma... |
US Patent US9505780 (2016)
BindingDB Entry DOI: 10.7270/Q22B8WZ1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer
| Assay Description Inhibitory activity can be determined routinely using known methods and also from commercial vendors offering this service for kinases and bromodomai... |
J Med Chem 50: 2647-54 (2007)
BindingDB Entry DOI: 10.7270/Q24170D7 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
SignalRx Pharmaceuticals, Inc.
US Patent
| Assay Description Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma... |
US Patent US9505780 (2016)
BindingDB Entry DOI: 10.7270/Q22B8WZ1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 214 | n/a | n/a | n/a | n/a | n/a | n/a |
SignalRx Pharmaceuticals, Inc.
US Patent
| Assay Description Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma... |
US Patent US9505780 (2016)
BindingDB Entry DOI: 10.7270/Q22B8WZ1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
SignalRx Pharmaceuticals, Inc.
US Patent
| Assay Description Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma... |
US Patent US9505780 (2016)
BindingDB Entry DOI: 10.7270/Q22B8WZ1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
SignalRx Pharmaceuticals, Inc.
US Patent
| Assay Description Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma... |
US Patent US9505780 (2016)
BindingDB Entry DOI: 10.7270/Q22B8WZ1 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase pim-1
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Arizona
Curated by ChEMBL
| Assay Description Inhibition of PIM1 (unknown origin) |
J Med Chem 56: 1922-39 (2013)
Article DOI: 10.1021/jm301522m BindingDB Entry DOI: 10.7270/Q2Z89DR9 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 289 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Arizona
Curated by ChEMBL
| Assay Description Inhibition of mTOR (unknown origin) |
J Med Chem 56: 1922-39 (2013)
Article DOI: 10.1021/jm301522m BindingDB Entry DOI: 10.7270/Q2Z89DR9 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 1.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Arizona
Curated by ChEMBL
| Assay Description Inhibition of PI3K p110gamma (unknown origin) |
J Med Chem 56: 1922-39 (2013)
Article DOI: 10.1021/jm301522m BindingDB Entry DOI: 10.7270/Q2Z89DR9 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Arizona
Curated by ChEMBL
| Assay Description Inhibition of PI3K p110alpha (unknown origin) |
J Med Chem 56: 1922-39 (2013)
Article DOI: 10.1021/jm301522m BindingDB Entry DOI: 10.7270/Q2Z89DR9 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Arizona
Curated by ChEMBL
| Assay Description Inhibition of PI3K p110delta (unknown origin) |
J Med Chem 56: 1922-39 (2013)
Article DOI: 10.1021/jm301522m BindingDB Entry DOI: 10.7270/Q2Z89DR9 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 214 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Arizona
Curated by ChEMBL
| Assay Description Inhibition of PI3K p110beta (unknown origin) |
J Med Chem 56: 1922-39 (2013)
Article DOI: 10.1021/jm301522m BindingDB Entry DOI: 10.7270/Q2Z89DR9 |
More data for this Ligand-Target Pair | |
BRD4 bromodomain 1
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
B.MOAD GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| PDB US Patent
| n/a | n/a | 241 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer
| Assay Description Inhibitory activity can be determined routinely using known methods and also from commercial vendors offering this service for kinases and bromodomai... |
J Med Chem 50: 2647-54 (2007)
BindingDB Entry DOI: 10.7270/Q24170D7 |
More data for this Ligand-Target Pair | ![3D 3D](/images/Docked_3d.png) 3D Structure (crystal) |
BRD4 bromodomain 2
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB
GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 1.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer
| Assay Description Inhibitory activity can be determined routinely using known methods and also from commercial vendors offering this service for kinases and bromodomai... |
J Med Chem 50: 2647-54 (2007)
BindingDB Entry DOI: 10.7270/Q24170D7 |
More data for this Ligand-Target Pair | |
PI3-kinase class I
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer
| Assay Description Inhibitory activity can be determined routinely using known methods and also from commercial vendors offering this service for kinases and bromodomai... |
J Med Chem 50: 2647-54 (2007)
BindingDB Entry DOI: 10.7270/Q24170D7 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit beta
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 214 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer
| Assay Description Inhibitory activity can be determined routinely using known methods and also from commercial vendors offering this service for kinases and bromodomai... |
J Med Chem 50: 2647-54 (2007)
BindingDB Entry DOI: 10.7270/Q24170D7 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer
| Assay Description Inhibitory activity can be determined routinely using known methods and also from commercial vendors offering this service for kinases and bromodomai... |
J Med Chem 50: 2647-54 (2007)
BindingDB Entry DOI: 10.7270/Q24170D7 |
More data for this Ligand-Target Pair | |
Bromodomain-containing protein 4 Bromo 2 domain(BRD4 BD2)
(Homo sapiens (Human)) | BDBM50427453
![PNG](/data/jpeg/tenK5042/BindingDB_50427453.png) (CHEMBL2322228 | US10308662, Compound 28 | US950578...)Show InChI InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2 | GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| US Patent
| n/a | n/a | 1.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SignalRx Pharmaceuticals, Inc.
US Patent
| Assay Description Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma... |
US Patent US9505780 (2016)
BindingDB Entry DOI: 10.7270/Q22B8WZ1 |
More data for this Ligand-Target Pair | |